• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

clinical trials

  1. Invitation to participate in a survey of clinical research professionals!

    Hello, I would like to invite clinical research professionals working within a biotechnology company or an academic institute on a clinical trial involving gene therapy in the US to participate in an ongoing research study! The goal of this research study is to measure your awareness and...
  2. Gilead failed, but Intercept succeeded

    Last week, Gilead failed in Phase 3 clinical trial for NASH drug. Today, Intercept has become the first player in the NASH area to complete a pivotal Phase 3 study in patients with liver fibrosis.
  3. Proteostasis Therapeutics stock reached double digits

    After announcing positive results for the treatment of cystic fibrosis, Proteostasis Therapeutics stock skyrocketed more than 400% and reached the double-digit mark after 18 months. https://news.alphastreet.com/proteostasis-therapeutics-stock-skyrockets-on-positive-cystic-fibrosis-trial-results/
  4. Celgene gets a booster shot from recent trial results

    In the past two weeks, Celgene has reported positive results from 3 clinical trials. This includes two studies with its partner Acceleron. https://news.alphastreet.com/celgene-gets-a-booster-shot-from-recent-positive-clinical-trial-results/
  5. Columbia University Student Requesting Assistance with Clinical Trials Matching Survey

    Hello, my colleagues and I at Columbia University are collecting data on cancer clinical trials to better understand the needs of the healthcare community. Please respond to the below questions and thank you in advance for taking the time to complete this questionnaire...